David Cameron says that we have reached a "tipping point" where the combination of new Alzheimer's treatments and new biotech and pharmaceutical companies could result in someone alive today having their Alzheimer's condition 'reversed.' He speaks at a Bloomberg.com subscriber event in London. (Source: Bloomberg)
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.
